Related scientific articles (all)

Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in Belgium.

Authors : Maertens J, Graux C, Breems D, Havelange V, Wittnebel S, Strens D, Hoefkens C
Year : 2017
Journal : Acta Clin Belg
Volume : 72(6)
Pages : 429-433

Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures.

Authors : Fayyad-Kazan M, Fayyad-Kazan H, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Year : 2017
Journal : Data Brief
Volume : 11
Pages : 442-445

Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites.

Authors : Fauquenoy S, Robette G, Kula A, Vanhulle C, Bouchat S, Delacourt N, Rodari A, Marban C, Schwartz C, Burny A, Rohr O, Van Driessche B, Van Lint C
Year : 2017
Journal : Sci Rep
Volume : 7
Pages : 43221

Results from the Belgian mantle cell lymphoma registry.

Authors : Vergote V, Janssens A, André M, Bonnet C, Van Hende V, Van Den Neste E, Van Eygen K, Maerevoet M, Pranger D, Schroyens W, Debussche S, Maertens V, Beel K, Lemmens J, Caron C, Delrieu V, Van Den Broeck I, Vanstraelen G, Jacquy C, Schauvlieghe L, De Samblanx H, Madoe V, Meers S, Boulet D, Verhoef G, van Hoof A
Year : 2017
Journal : Acta Clin Belg
Volume : 72(3)
Pages : 172-178

Corrigendum to Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410]."

Authors : Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Year : 2016
Journal : J Geriatr Oncol
Volume : 7
Pages : 142-143

Onco-haematology geriatry : impact of cognitive disorders.

Authors : Dubruille S, Libert Y, Razavi D, Bron D
Year : 2016
Journal : Belgian J Hematology
Volume : 7
Pages : 180-3

Belgium recommendations for the management of acute promyelocytic leukaemia

Authors : Wittnebel S
Year : 2016
Journal : Belgian J Hematology
Volume : 7
Pages : 224-8

Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.

Authors : Gratwohl A, Iacobelli S, Bootsman N, van Biezen A, Baldomero H, Arcese W, Arnold R, Bron D, Cordonnier C, Ernst P, Ferrant A, Frassoni F, Gahrton G, Richard C, Kolb HJ, Link H, Niederwieser D, Ruutu T, Schattenberg A, Schmitz N, Torres-Gomez A, Zwaan F, Apperley J, Olavarria E, Kröger N
Year : 2016
Journal : Ann Hematol
Volume : 95(6)
Pages : 967-72

BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias

Authors : Delrieu V, Wu KL, Schroyens W, Bonnet C, Bron D, Janssens A
Year : 2016
Journal : Belgian J Hematology
Volume : 7
Pages : 103-11

Progression-free survival as surrogate endpoint for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer.

Authors : Michiels S, Pugliano L, Marguet S, Grun D, Barinoff J, Cameron D, Cobleigh M, Di Leo A, Johnston S, Gasparini G, Kaufman B, Marty M, Nekjudova V, Paluch-Shimon S, Penault-Llorca F, Slamon D, Vogel C, Von Minckwitz G, Buyse M, Piccart-Gebhart M
Year : 2016
Journal : Ann Oncol
Volume : 27(6)
Pages : 1029-34

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

Authors : Kourie HR, Ameye L, Paesmans M, Bron D
Year : 2016
Journal : Clin Lymphoma Myeloma Leuk
Volume : 16(5)
Pages : 264-8

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.

Authors : Van Damme M, Crompot E, Meuleman N, Maerevoet M, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Year : 2016
Journal : Clin Epigenetics
Volume : 8
Pages : 132

Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.

Authors : Najar M, Raicevic G, André T, Fayyad-Kazan H, Pieters K, Bron D, Toungouz M, Lagneaux L
Year : 2016
Journal : Cytotherapy
Volume : 18
Pages : 320-35

The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.

Authors : Najar M, Raicevic G, Crompot E, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Year : 2016
Journal : J Immunother
Volume : 39
Pages : 45-59

The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.

Authors : Van Kempen LC, Redpath M, Elchebly M, Klein KO, Papadakis AI, Wilmott JS, Scolyer RA, Edqvist PH, Pontén F, Schadendorf D, van Rijk AF, Michiels S, Dumay A, Helbling-Leclerc A, Dessen P, Wouters J, Stass M, Greenwood CM, Ghanem G, van den Oord J, Feunteun J, Spatz A
Year : 2016
Journal : Sci Transl Med
Volume : 8
Pages : 369ra177

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.

Authors : Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Year : 2016
Journal : Cytotherapy
Volume : 18
Pages : 160-71

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

Authors : Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Loi S, Smyth MJ
Year : 2016
Journal : Cancer Res
Volume : 76
Pages : 264-74

Serum free light chains should be the target of response evaluation in light chain multiple myeloma rather than urines.

Authors : Dejoie T, Corre J, Caillon H, Hulin C, Perrot A, Caillot D, Boyle E, Chretien ML, Fontan J, Belhadj K, Brechignac S, Decaux O, Voillat L, Rodon P, Fitoussi O, Araujo C, Benboubker L, Fontan C, Tiab M, Godmer P, Luycx O, Allangba O, Pignon JM, Fuzibet JG, Legros L, Stoppa AM, Dib M, Pegourie B, Orsini-Piocelle F, Karlin L, Arnulf B, Roussel M, Garderet L, Mohty M, Meuleman N, Doyen C, Lenain P, Macro M, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H
Year : 2016
Journal : Blood
Volume : 128(25)
Pages : 2941-48

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.

Authors : Fumagalli D, Wilson TR, Salgado R, Lu X, Yu J, OBrien C, Walter K, Huw LY, Criscitiello C, Laios I, Jose V, Brown DN, Rothé F, Maetens M, Zardavas D, Savas P, Larsimont D, Piccart-Gebhart M, Michiels S, Lackner MR, Sotiriou C, Loi S
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : 1860-6

Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.

Authors : Kourie HR, Ameye L, Paesmans M, Bron D
Year : 2016
Journal : Ann Hematol
Volume : 95(12)
Pages : 2105-2106